Anal Fistula Surgical Treatment Market Size is estimated to grow at a significant rate from 2022 to 2028 with increasing cases of tuberculosis, sexually transmitted disease and Crohn’s disease. Besides, soaring cases of chronic diarrhea across emerging economies will expedite the demand for fistula surgical treatment.
Infection in anal fistula has become prevalent globally, leading to pus, swelling and pain. The majority of anal fistulas tend to form in reaction to an anal gland that has developed an abscess. Surgical procedures, such as seton techniques, fistulotomy, bioprosthetic plug and advancement flap procedures are expected to be sought-after across North America, Europe and Asia Pacific. Besides, a rising patient population with inflammatory bowel disease and healthcare expenditure will fuel the adoption of fistula surgical treatment solutions.
In terms of treatment type, anal fistula surgical treatment market share from fistulotomy will grow during the forecast period 2022-2028. Fistulotomy has gained traction to drain fluids and pus from fistulated tissues, enabling them to heal. Besides, the surgery has become sought-after to reduce injury to the anal sphincter. Industry participants are expected to invest in fistulotomy that has become popular for quick and effective treatment.
Based on anal fistula type, transphincteric fistula will contribute a notable share towards global market. Recurrences in the form of a persistent transphincteric tract will further the need for fistula surgical treatment. Expanding medical tourism in the U.S. and European countries will boost the penetration of surgical treatment.
With respect to region, North America anal fistula surgical treatment market outlook will be strong over 2022-2028. A notable uptick in the number of people suffering from inflammatory bowel disease (IBD) in the U.S. has led to investments in novel technologies. Moreover, the prevalence of AIDS has also played a pivotal role in boosting the penetration of advanced flap procedures and seton techniques.
The competitive landscape of global anal fistula surgical treatment market indicates leading companies could invest in mergers & acquisitions, product launches, R&D activities and innovations. Some of the major players in the landscape are Bumrungrad International Hospital, Renacres Hospital, Apollo Hospitals Enterprise Ltd., Royal Prince Alfred Hospital, St. Mark's Hospital, Stanford Health Care, Fortis Healthcare, Alberta Health Services, St. Mark's Hospital and Sikarin Hospital, among others.
In June 2021, Stanford Health Care upped its investment and donated around UD 861 million in funds and services to help healthcare workers, patients and NPOs address pandemic-related needs. In April 2020, Scientists at Stanford University developed a smart toilet that uses biometrics to detect people’s butts and assess their poop.
Industry participants grappled with healthcare disruptions as hospitals, ambulatory surgical centers and other stakeholders shifted their investments toward overcoming COVID-19 pandemic. For instance, in January 2021, HCA Healthcare joined hands with A Plus International to bolster the access of personal protective equipment (PPE). So much so that 2020 spending of HCA Healthcare for PPE surged by over USD 196 million as compared to 2019. Meanwhile, rising cases of IBDs, including ulcerative colitis and Crohn's Disease have prompted governments and leading companies to invest in anal fistula surgical treatment solutions.
The emergence of video-assisted and fistula treatment (VAAFT) devices has augured well for the business outlook. It can enable surgeons to see inside the anal fistula tract and help locate the internal opening. The use of video telescopes could gain further traction to bring a paradigm shift in the global market.
Market, By Treatment type
Market, By Anal fistula type
The above information is provided for the following regions and countries: